- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: fingolimod (FTY720)
Total 104 results
-
University Hospital, Basel, SwitzerlandNovartisCompletedRett's SyndromeSwitzerland
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
NovartisCompletedRenal InsufficiencyRussian Federation
-
Tianjin Medical University General HospitalCompletedStroke | Stroke, Acute | Cerebral Stroke | Ischemic Cerebrovascular Accident | Vascular AccidentChina
-
Novartis PharmaceuticalsCompletedMultiple SclerosisItaly, Belgium, Germany
-
Novartis PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisGermany, South Africa, Italy, United States, Austria, Belgium, Czechia, Egypt, Hungary, Malaysia, Turkey, Spain, Australia, Canada, France, Israel, Netherlands, Switzerland, Greece, Korea, Republic of, Romania, Russian Federation, United... and more
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis RRMSGermany, Switzerland
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
The Methodist Hospital Research InstituteEnrolling by invitationKidney Failure, Chronic | Kidney Transplant Rejection | Graft Rejection | Kidney Transplant; Complications | Kidney Transplant Failure | Kidney Transplant Failure and Rejection | Interstitial FibrosisUnited States
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingRelapsing Multiple Sclerosis (RMS)China
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast CarcinomaUnited States
-
University Hospital MuensterNovartisUnknownRelapsing Remitting Multiple SclerosisGermany
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPain | Chemotherapy-Induced Peripheral Neuropathy | Numbness | TinglingUnited States
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisSpain, Australia
-
Novartis PharmaceuticalsTerminatedRelapsing-remitting Multiple Sclerosis (RRMS)United States, Canada, Mexico, Brazil, Puerto Rico, Argentina, Chile
-
NovartisCompletedRelapsing Multiple SclerosisGermany, Italy, Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, Greece, Hungary, Ireland, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovakia, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Novartis PharmaceuticalsTerminatedPrimary Progressive Multiple SclerosisUnited States, Belgium, Poland, Germany, Hungary, Turkey, Spain, Australia, Canada, Czechia, Switzerland, United Kingdom, Netherlands, France, Italy, Denmark, Finland, Sweden
-
Novartis PharmaceuticalsCompletedKidney Transplantation
-
NovartisCompletedMultiple SclerosisSwitzerland, Germany, Spain, Portugal, Canada, Denmark, Finland, France, Italy, Poland, United Kingdom
-
NovartisCompletedAsthmaUnited Kingdom
-
NovartisCompletedRelapsing Multiple SclerosisBelgium, Poland, Spain, France, United Kingdom, Guatemala, Canada, Finland, Switzerland
-
NovartisMitsubishi Tanabe Pharma CorporationCompletedMultiple SclerosisJapan
-
NovartisCompleted
-
Novartis PharmaceuticalsRecruitingMultiple Sclerosis (MS)United States, Belgium, Taiwan, Italy, Germany, Canada, Estonia, Mexico, Turkey, Croatia, Slovakia, India, Spain, Argentina, France, Israel, Australia, Austria, Serbia, Brazil, Guatemala, Latvia, Poland, Portugal, Russian Federation, Romania and more
-
Novartis PharmaceuticalsWithdrawnAcute Noninfectious Posterior, Intermediate, or Pan Uveitis
-
Novartis PharmaceuticalsCompletedKidney Transplantation
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
Novartis PharmaceuticalsCompletedSTudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START) (START)Multiple SclerosisGermany
-
Novartis PharmaceuticalsCompletedRenal Transplantation
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedRenal Transplantation
-
Novartis PharmaceuticalsCompletedRenal Transplantation
-
Novartis PharmaceuticalsMitsubishi Tanabe Pharma CorporationCompletedRenal Transplantation
-
Isfahan University of Medical SciencesShiraz University of Medical SciencesCompleted
-
Novartis PharmaceuticalsCompletedRenal Transplantation
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
Novartis PharmaceuticalsCompletedKidney TransplantationUnited States
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisBelgium, Canada, Spain, United States, Hungary, India, Italy, Mexico, Portugal, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Argentina, Australia, Bulgaria, France, Greece, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
Novartis PharmaceuticalsWithdrawnMultiple Sclerosis (Relapsing Remitting)
-
University Hospital, CaenRecruitingMultiple SclerosisFrance
-
Asofarma S.A.I. y C.Zenith Technology Corporation LimitedCompletedHealthy VolunteersNew Zealand
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
Novartis PharmaceuticalsCompletedMultiple SclerosisColombia, Panama, Peru, Brazil, Jordan, Malaysia, Mexico, Argentina
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
Heinrich-Heine University, DuesseldorfNovartis PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisGermany
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | Relapsing-RemittingTurkey
-
Novartis PharmaceuticalsTerminatedRelapsing Remitting Multiple Sclerosis (RRMS)Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland